Publicaciones
-
Filbin MG, Tirosh I, Hovestadt V, Shaw ML, Escalante LE, Mathewson ND, Neftel C, Frank N, Pelton K, Hebert CM, Haberler C, Yizhak K, Gojo J, Egervari K, Mount C, van Galen P, Bonal DM, Nguyen QD, Beck A, Sinai C, Czech T, Dorfer C, Goumnerova L, Lavarino C, Carcaboso AM, Mora J, Mylvaganam R, Luo CC, Peyrl A, Popovic M, Azizi A, Batchelor TT, Frosch MP, Martinez-Lage M, Kieran MW, Bandopadhayay P, Beroukhim R, Fritsch G, Getz G, Rozenblatt-Rosen O, Wucherpfennig KW, Louis DN, Monje M, Slavc I, Ligon KL, Golub TR, Regev A, Bernstein BE and Suvà ML.
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq
SCIENCE . 360(6386): 331-335. Nº de citas: 415
-
Gomez-Gonzalez S, Garrido- García A, García-Gerique L, Lemos I, Suñol M, de Torres C, Kulis M, Pérez-Jaume S, Carcaboso AM, Luu B, Kieran MW, Jabado N, Kozlenkov A, Dracheva S, Ramaswamy V, Hovestadt V, Johann P, Jones DTW, Pfister SM, Morales-La Madrid A, Cruz-Martínez O, Taylor MD, Martín-Subero JI, Mora J and Lavarino C.
A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
CLINICAL CANCER RESEARCH . 24(6): 1355-1363. Nº de citas: 22
-
Masvidal L, Iniesta R, Garcia-López M, Casalà C, Lavarino C, Mora J and de Torres C.
Genetic Variants in the Promoter Region of the Calcium-Sensing Receptor Gene Are Associated With Its Down-Regulation in Neuroblastic Tumors
MOLECULAR CARCINOGENESIS . 56(4): 1281-1289. Nº de citas: 13
-
Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Gene-Olaciregui N, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM and Helin K.
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
NATURE MEDICINE . 23(4): 483-492. Nº de citas: 390
-
Monterrubio C, Paco-Mercader S, Gene-Olaciregui N, Pascual-Pastó G, Vilà-Ubach M, Cuadrado-Vilanova M, Ferrandiz MM, Castillo-Ecija H, Glisoni R, Kuplennik N, Jungbluth A, de Torres C, Lavarino C, Cheung NV, Mora J, Sosnik A and Carcaboso AM.
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8
JOURNAL OF CONTROLLED RELEASE . 255: 108-119. Nº de citas: 35
-
Salas S, Agut-Quijano T, Rovira-Zurriaga C, Canizo D, Lavarino C and García-Alix A.
Infratentorial congenital glioblastoma multiforme. A rare tumour with a still unknown biology
REVISTA DE NEUROLOGIA . 63(9): 411-414. Nº de citas: 2
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Nº de citas: 26
-
Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein
Oncotarget . 7(29): 46283-46300. Nº de citas: 12
-
Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
Oncotarget . 7(13): 16112-16129. Nº de citas: 17
-
Gomez-Gonzalez S, Castellano G, Mayol G, Queiros A, Martín-Subero JI and Lavarino C.
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
Genomics data . 5: 360-363. Nº de citas: 5